This program is preliminary and subject to change

Time Session

 

IATDMCT Council Meeting

 

PreCongress Symposium

Update on the TDM of Mycophenolate

1600 – 1730

Welcome Remarks

Opening Plenary: Big Data / Artificial Intelligence
Johan Saba, Seed AI, Canada

1730 – 1900

Welcome Reception

0800 – 0830

IATDMCT C.E. Pippenger Award

0830 – 0900

IATDMCT Victor Armstrong Young Investigator Award

0900 – 1000

Plenary Session: The Impact of Glyphosate-Based Herbicides (eg. Round-Up)
Laura N. Vandenberg, University of Massachusetts – Amherst School of Public Health & Health Sciences, USA

1000 – 1030

Refreshment Break

1030 – 1230

Concurrent Symposia

  • Concurrent Symposium 1: Pro/Con session regarding TDM of mAb therapies in oncology
  • Concurrent Symposium 2: Therapeutic drug monitoring of biologics in immune mediated inflammatory diseases: reflexions for the present and future
  • Concurrent Symposium 3: Novel strategies for improving personalized immunosuppression in transplantation

1230 – 1400

Lunch, Poster Presentations, Industry Workshops

1400 – 1530

Concurrent Symposia & Oral Presentations

  • Concurrent Symposium 4: Alternative sampling strategies to evaluate in utero drug exposure
  • Oral Presentations

1530 – 1600

Refreshment Break

1600 – 1730

Concurrent Symposia & Oral Presentations

  • Concurrent Symposium 5: Ecotoxicological modeling for pharmaceutical pollutants
  • Concurrent Symposium 6: Dose adjustment in patients with changing renal function (1 hour) + How comparable are we? Lessons from the College of American Pathologists proficiency testing surveys (30 minutes)
  • Oral Presentations

1730 – 1800

IATDMCT Committee Meetings

1800 – 1930

Wine & Cheese Reception in the Exhibit Hall

1930

Young Scientist Dinner

0800 – 0900

IATDMCT Annual Members’ Meeting

0900 – 1000

Plenary Session: Opioid Crisis
Hakique Virani, University of Alberta, Canada

1000 – 1030

Refreshment Break

1030 – 1230

Concurrent Symposia

  • Concurrent Symposium 7: Non-conventional but critical sources of exposure to Endocrine Disrupting compounds (EDC)
  • Concurrent Symposium 8: The growing problem of dosing the obese patient: what the Product Information doesn’t tell you
  • Concurrent Symposium 9: Precision medicine in psychiatry

1230 – 1400

Lunch, Poster Presentations, Industry Workshops

1400 – 1530

Concurrent Symposia & Oral Presentations

  • Concurrent Symposium 10: Pragmatic Approaches to Improvements in Pediatric Drug Therapy
  • Oral Presentations

1530 – 1600

Refreshment Break

1600 – 1730

Concurrent Symposia & Oral Presentations

  • Concurrent Symposium 11: Fast and furious: pithy patient practice points
  • Concurrent Symposium 12: Cannabinoid
  • Oral Presentations

1730 – 1800

IATDMCT Committee Meetings

1830 – 2200

Congress Banquet at Mountview

0830 – 1000

Oral Presentations

1000 – 1030

Refreshment Break

1030 – 1230

Concurrent Symposia

  • Concurrent Symposium 13: Implementation of TDM – Secrets of Success
  • Concurrent Symposium 14: Drug Abuse Challenges in the World
  • Concurrent Symposium 15: Young Scientist Committee Symposium

1230 – 1400

Lunch, Poster Presentations, Industry Workshops

1400 – 1530

Plenary Debate: Genotyping vs Phenotyping
Pierre Marquet, Université de Limoges, France
Ron van Schaik, Erasmus University Medical Center, Netherlands

1530 – 1600

Closing Ceremonies